First-in Cancer-Type Phase I Study of FT536 for Recurrent WHO Grade 4 Astrocytoma

Abroad (travel likely)RecruitingPHASE1

Conditions

Astrocytoma · Glioblastoma · Progressive Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Elizabeth C. Neil, MD, Minneapolis, Minnesota, United States
Contact: Study coordinator (Elizabeth C. Neil, MD) · neile@umn.edu · 612-273-8383

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma

Childhood Astrocytoma · Childhood Diffuse Intrinsic Pontine Glioma · Childhood Diffuse Midline Glioma

Abroad (travel likely)RecruitingPHASE1

Birmingham, United States · Los Angeles, United States

Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

Glioblastoma · Anaplastic Astrocytoma · Anaplastic Oligoastrocytoma

Abroad (travel likely)RecruitingPHASE2

New York, United States

HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM

Glioblastoma Multiforme · Astrocytoma, Grade III

Abroad (travel likely)RecruitingPHASE1, PHASE2

Houston, United States

The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients.

Glioblastoma · Glioblastoma Multiforme · Glioblastoma Multiforme of Brain

Abroad (travel likely)Recruiting

Ghent, Belgium · Tilburg, Netherlands